A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)
Year: 2019
Type: conference-abstract
Source: Blood
Institutions: Medical College of Wisconsin, Mayo Clinic, Froedtert Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2987022376
